首页/数据集/Supplementary Table 4 from Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

Supplementary Table 4 from Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

NIAID Data Ecosystem2026-05-26 收录

数据链接：

https://figshare.com/articles/dataset/Supplementary_Table_4_from_Activated_d16HER2_Homodimers_and_SRC_Kinase_Mediate_Optimal_Efficacy_for_Trastuzumab/22403594 数据链接链接失效反馈

官方服务：

资源简介：

List of cases of the GSE 55348.

应用场景：

创建时间：

2014-11-01

HER2阳性乳腺癌

药物反应预测

Thirteen HER2 positive breast cancer cell lines were screened with 22 commercially available compounds, mainly targeting proteins in the ErbB2 signaling pathway, and the molecular mechanisms related t

NIAID Data Ecosystem80

Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice supplementary table

心力衰竭治疗

药物疗效预测

Aim: To estimate the projected effectiveness of dapagliflozin in subjects with heart failure (HF) with reduced ejection fraction in clinical practice in Spain. Materials & methods: This multicente

DataCite Commons2024-05-18 更新60

RNA-seq of MMTV-Neu AXL KO tumors

HER2阳性乳腺癌

AXL受体酪氨酸激酶

AXL is activated by its ligand GAS6 and is expressed in triple-negative breast cancer cells. We report that AXL is also detected in HER2+ breast cancer specimens where its expression correlates with p

NIAID Data Ecosystem30

Additional file 2: of Context-specific functional module based drug efficacy prediction

药物疗效预测

模型评估

Comparison concordance index between our model and elastic net. It contains concordance index of our model and elastic net in each drug. It contains p-value of concordance index of our model and elast

DataCite Commons2024-12-17 更新80

BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer

HER2阳性乳腺癌

单细胞RNA测序

.rda file for Seurat object of scRNA-seq data from BT474 breast cancer cell lines treated with DMSO, Neratinib, Fulvestrant, and a combination of Neratinib and Fulvestrant.

Zenodo2023-05-04 更新30

Supplementary Table 4 from Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

资源简介：

相关数据集